Prostate Cancer

If you have prostate cancer, you have choices.

Our deep devotion to research and clinical trials provides our patients with access to state-of-the-art care before it is available to the public. This includes groundbreaking advancements in these prostate cancer treatments:

• Radioligand targeted therapy: Groundbreaking new medications that deliver a small dose of radiation attached to a molecule that specifically binds to cancer cells. The FDA has already approved one, and MIU is actively involved in a next generation radioligand clinical trial and is currently recruiting patients.
• Advanced immunotherapy: This treatment stimulates your body’s immune system to find and destroy cancer cells, with advancements that help the body track down more elusive cancer cells.
• Cryotherapy: Also called cryosurgery or cryoablation, this therapy uses very cold temperatures to freeze and kill prostate cancer cells.
• TURP: A man with advanced prostate cancer may choose TURP (transurethral resection of the prostate) to relieve symptoms. The surgeon inserts a long, thin scope through the urethra. A cutting tool at the end of the scope removes tissue from the inside of the prostate. TURP may not remove all of the cancer, but it can remove tissue that blocks the flow of urine.
• Hormone therapy: Medications block the production of testosterone, which feeds cancer cells. Without its energy source, the cancer slows and potentially shrinks.
• Surgical removal of the prostate
• Radiation therapy
  • Stereotactic body radiation therapy: Delivers high doses of radiation in a small number of treatment sessions – five outpatient sessions on consecutive days or over a two-week period.
  • Intensity modulated radiation therapy: Computer-guided radiation is targeted at the cancer cells in daily sessions, over several weeks.
  • Brachytherapy: Radioactive treatments are delivered directly into the prostate in 1-2 treatments.

LEARN MORE about prostate cancer here.